RxDoctor Payments Data

Elyse Julian, DO

Dermatology · Plantation, FLNPI 1851743587

Payments from drug & device makers

$300,221in general payments, 2019–2025

Across 488 payments — averaging $615.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$271K
  • Sanofi Pasteur Inc.$18K
  • AbbVie$2K
  • Sanofi$1K
  • Lilly USA, LLC$856
  • Regeneron Healthcare Solutions, Inc.$809
  • plus $6K from 29 others
$34,006in research payments, 2019–2025

Across 3 payments — averaging $11,335 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$34K

What the payments were for

  • Speaking & faculty fees$3503%
  • Food & beverage$10,32494%
  • Education$3243%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$300,221 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$430,586
Medicare patients
405
Services billed
2,861

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab26$105,584
Humira(Cf) PenAdalimumab12$85,564
Clobetasol Propionate92$3,263
Ketoconazole215$2,971
Tacrolimus17$2,112
Fluocinolone Acetonide16$938
Metronidazole17$871
Ciclopirox30$765
Tretinoin18$756
Triamcinolone Acetonide112$684
ValacyclovirValacyclovir Hcl23$654
Mometasone Furoate27$494
Doxycycline Hyclate45$488
Mupirocin69$374
Nystatin25$320

Paid to pharmacies, not to this prescriber.

Other dermatology in Plantation

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →